Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finn

Showing results (351-360 of 527) with videos related to

Pageof 53
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 22, 2021
Functional connectivity during frustration: a preliminary study of predictive modeling of irritability in youthDustin Scheinost, Javid Dadashkarimi, Emily S Finn, et al.
British Journal of Cancer|June 29, 2019
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
British Journal of Cancer|August 1, 2019
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|October 20, 2020
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinomaSaleh A Alqahtani, Faisal M Sanai, Ashwaq Alolayan, et al.
Psychological Science|January 18, 2014
Cognitive skills, student achievement tests, and schoolsAmy S Finn, Matthew A Kraft, Martin R West, et al.
Molecular Cancer Therapeutics|July 1, 2010
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell linesEdward B Garon, Richard S Finn, Wylie Hosmer, et al.
Future Oncology (London, England)|April 11, 2019
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaShukui Qin, Richard S Finn, Masatoshi Kudo, et al.
Breast Cancer Research and Treatment|February 10, 2015
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of responseSara A Hurvitz, Ondrej Kalous, Dylan Conklin, et al.
Journal of Hand Surgery Global Online|December 24, 2025
Infantile Fibrosarcoma of the Hand: Limb-Sparing Treatment With Modern Targeted Oral Chemotherapy and Conservative Surgical ResectionJohn R Vaile, John A Tipps, Rachel Hurley, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
COQ2 nephropathy: a treatable cause of nephrotic syndrome in childrenMichelle C Starr, Irene J Chang, Laura S Finn, et al.
Pageof 53

Showing results (351-360 of 527) with videos related to

Sort By:
Pageof 53
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 22, 2021
Functional connectivity during frustration: a preliminary study of predictive modeling of irritability in youthDustin Scheinost, Javid Dadashkarimi, Emily S Finn, et al.
British Journal of Cancer|June 29, 2019
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
British Journal of Cancer|August 1, 2019
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinomaThomas R Jeffry Evans, Masatoshi Kudo, Richard S Finn, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|October 20, 2020
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinomaSaleh A Alqahtani, Faisal M Sanai, Ashwaq Alolayan, et al.
Psychological Science|January 18, 2014
Cognitive skills, student achievement tests, and schoolsAmy S Finn, Matthew A Kraft, Martin R West, et al.
Molecular Cancer Therapeutics|July 1, 2010
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell linesEdward B Garon, Richard S Finn, Wylie Hosmer, et al.
Future Oncology (London, England)|April 11, 2019
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaShukui Qin, Richard S Finn, Masatoshi Kudo, et al.
Breast Cancer Research and Treatment|February 10, 2015
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of responseSara A Hurvitz, Ondrej Kalous, Dylan Conklin, et al.
Journal of Hand Surgery Global Online|December 24, 2025
Infantile Fibrosarcoma of the Hand: Limb-Sparing Treatment With Modern Targeted Oral Chemotherapy and Conservative Surgical ResectionJohn R Vaile, John A Tipps, Rachel Hurley, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
COQ2 nephropathy: a treatable cause of nephrotic syndrome in childrenMichelle C Starr, Irene J Chang, Laura S Finn, et al.
Pageof 53